BHRT may help some women with disruptive peri- or menopause-related symptoms—and may be unnecessary or inappropriate for others. Candidacy is a clinical judgment, not a quiz badge. This page outlines who is typically evaluated for BHRT at KAYU Health, when we pause or refer, and what labs help decide.
California-only. Clinicians: Narine Chilyan, DNP, AGNP-C · Dr. Aram Mkhitarian, DO. Membership (Consult $49.99 · Root $199 · Branch $499 · Canopy $799) is care pricing; pharmacy is separate at cost.
Candidate profiles we commonly see
Perimenopause with disruptive clusters. Hot flashes, sleep disruption, mood volatility, cycle changes, brain fog, or metabolic shifts that track with hormonal transition — see perimenopause overview and the 34 symptoms map.
Menopause transition or postmenopause with quality-of-life impact. Vasomotor symptoms, genitourinary syndrome patterns, sleep and mood changes, where benefits and risks are weighed explicitly.
Women seeking clinician-led care over supplement stacks alone. Education on estrogen/progesterone basics belongs in care conversations — /bhrt/estrogen-progesterone-basics.
California residents ready for labs and follow-up. Telehealth rules and monitoring are part of the product.
When we pause, delay, or refer
High-level patterns (not an exhaustive medical legal list):
- Active concerns that need urgent in-person evaluation (e.g., suspicious bleeding patterns requiring workup)
- History of conditions where systemic HRT may be contraindicated or highly cautioned—your clinician will apply guidelines and individual risk
- Unwillingness to complete labs or follow-up
- Primary issue better led by another specialty first
- Residence outside California
Deep safety content will live on /bhrt/risks-and-contraindications (P1). This page stays at orientation level on purpose.
Labs that help decide
Women’s labs are interpreted with cycle timing (when relevant), age/stage, symptoms, and history. Sex hormones, thyroid markers, and metabolic labs may all appear depending on the story. Numbers without context are not a green light.
Membership expectations
If you are a candidate and choose to proceed, pick a tier that matches follow-up needs. Root, Branch, and Canopy differ in care intensity—not in “stronger hormones.” Medications, when prescribed, remain pharmacy-separate. Compare tiers: Root vs Branch vs Canopy.
Peri vs meno — why the distinction matters
Perimenopause can include wild swings; menopause staging changes what “normal” looks like and which goals dominate (symptom relief, bone/heart risk discussions, genitourinary care, etc.). Clinicians tailor; marketing slogans should not.
Next step
Take the BHRT path in /quiz or /book a consult. Bring symptom timing notes (cycle diary if still cycling), medication list, and priorities. You will leave with clarity: candidate, not yet, or refer—delivered by a named California clinician.
Shared decision-making in practice
A strong candidacy conversation includes your goals, non-goals, risk tolerance, and monitoring bandwidth. Some women want aggressive symptom relief; others want the lightest effective intervention. Both can be reasonable. What is not reasonable is hiding contraindications or skipping labs because a podcast promised miracles.
Bring questions: What are alternatives to systemic hormones? What local options exist for genitourinary symptoms? How will we monitor? What symptoms should trigger a same-week message versus routine follow-up? Named California clinicians will answer in plain English.
Edge cases to mention in intake
- Prior blood clots or high personal/family clotting risk
- Hormone-sensitive cancer history
- Unexplained postmenopausal bleeding
- Active liver disease concerns
- Migraine with aura patterns that change risk discussions
- Smoking status and cardiovascular risk stacking
These are conversation starters for clinicians—not internet self-disqualification rules. Do not hide them to “get approved.” Honest intake protects you.
How candidacy relates to the 34-symptoms map
You do not need a high symptom count to be a candidate, and a long symptom list does not force BHRT. Function disruption, stage, labs, and risk profile decide. Use the 34 symptoms map to prepare, then let Narine Chilyan, DNP, AGNP-C or Dr. Aram Mkhitarian, DO interpret the pattern under California telehealth rules. Membership remains separate from pharmacy; Canopy is not a higher dose.
What a good candidacy visit feels like
You should leave with a plain-English status: candidate, not yet, or refer—and with next steps written clearly (labs, diary, specialist referral, or membership choice). You should understand that Root, Branch, and Canopy change care intensity, not “hormone strength,” and that pharmacy—if prescribed later—is billed separately.
If your goals include sleep restoration, hot-flash reduction, genitourinary comfort, or metabolic stability, rank them. Clinicians titrate to goals and safety, not to social media timelines.
Putting candidacy together
Strong evaluation candidates usually show disruptive peri- or menopause-related clusters, California residency, willingness to complete labs, and readiness for follow-up. Non-candidates—or pause cases—usually include urgent bleeding needing in-person workup, contraindication patterns, out-of-state residence, or refusal of monitoring. Between those poles sits “not yet”: optimize adjacent issues, repeat labs, or gather history.
Continue reading /bhrt/perimenopause-overview and /bhrt/34-symptoms-map, then /book or /quiz. Care membership Consult $49.99 · Root $199 · Branch $499 · Canopy $799; pharmacy separate at cost.
California BHRT candidacy in one sentence
You are a candidate to evaluate when disruptive peri- or menopause-related symptoms, labs, risk review, and California telehealth logistics align—and not a candidate to rush when red-flag bleeding, contraindications, or missing workup require pause or referral. Start with /book or /quiz for a named-clinician decision.
Membership reminder specific to candidates
Choosing Branch or Canopy does not make you “more approved.” Approval is clinical. Tier choice is how much structured follow-up you want after a yes. If the answer is not yet, you should not be upsold into Canopy to unlock a prescription that was not indicated. That boundary is intentional California care culture at KAYU.